Home › Compare › VRCDF vs BTI

VRCDF vs BTI: Dividend Comparison 2026

VRCDF yields 66666.67% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRCDF wins by $8.441837856534449e+24M in total portfolio value
10 years
VRCDF
VRCDF
● Live price
66666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.441837856534449e+24M
Annual income
$8,417,001,582,403,749,000,000,000,000,000.00
Full VRCDF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — VRCDF vs BTI

📍 VRCDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRCDFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRCDF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VRCDF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRCDF
Annual income on $10K today (after 15% tax)
$5,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,154,451,345,043,187,000,000,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, VRCDF beats the other by $7,154,451,345,043,187,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRCDF + BTI for your $10,000?

VRCDF: 50%BTI: 50%
100% BTI50/50100% VRCDF
Portfolio after 10yr
$4.2209189282672247e+24M
Annual income
$4,208,500,791,201,874,400,000,000,000,000.00/yr
Blended yield
99.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

VRCDF
No analyst data
Altman Z
-19.5
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRCDF buys
0
BTI buys
0
No recent congressional trades found for VRCDF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRCDFBTI
Forward yield66666.67% ✓5.40%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$8.441837856534449e+24M$37.8K ✓
Annual income after 10y$8,417,001,582,403,749,000,000,000,000,000.00 ✓$2,802.29
Total dividends collected$8.44020886744369e+24M$14.4K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: VRCDF vs BTI ($10,000, DRIP)

YearVRCDF PortfolioVRCDF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$6,677,367$6,666,666.67$11,301$601.08+$6.67M → VRCDF
2$4,167,497,846$4,160,353,063.34$12,799$706.58+$4167.49M → VRCDF
3$2,431,161,901,635$2,426,702,678,939.67$14,527$832.38+$2431161.89M → VRCDF
4$1,325,636,209,022,888$1,323,034,865,788,139.00$16,527$982.75+$1325636209.01M → VRCDF
5$675,632,775,263,916,700$674,214,344,520,262,300.00$18,846$1,162.95+$675632775263.90M → VRCDF
6$321,867,481,182,444,260,000$321,144,554,112,911,900,000.00$21,545$1,379.49+$321867481182444.25M → VRCDF
7$143,326,993,661,751,470,000,000$142,982,595,456,886,240,000,000.00$24,694$1,640.41+$143326993661751472.00M → VRCDF
8$59,657,925,421,851,500,000,000,000$59,504,565,538,633,426,000,000,000.00$28,378$1,955.69+$59657925421851500544.00M → VRCDF
9$23,211,471,150,187,795,000,000,000,000$23,147,637,169,986,416,000,000,000,000.00$32,702$2,337.79+$2.3211471150187796e+22M → VRCDF
10$8,441,837,856,534,450,000,000,000,000,000$8,417,001,582,403,749,000,000,000,000,000.00$37,794$2,802.29+$8.441837856534449e+24M → VRCDF

VRCDF vs BTI: Complete Analysis 2026

VRCDF — Stock

Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its in-development tests include Clarava, a pre-transplant prognosis test for the risk of early acute rejection; Tuteva, a post-transplant test that focuses on acute cellular rejection; and Protega, a liquid biopsy that aims to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Penarth, the United Kingdom.

Full VRCDF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this VRCDF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRCDF vs SCHDVRCDF vs JEPIVRCDF vs OVRCDF vs KOVRCDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.